Latest Breaking News On - Translational research conference - Page 1 : comparemela.com

Rakovina Therapeutics Inc Announces 2023 Financial Results and Provides Corporate Update

Rakovina Therapeutics Inc Announces 2023 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesBritish columbiaPetra hamerlikArtem cherkasovJournal of clinical cancer researchVancouver prostate centerRegulation services providerUniversity of manchesterRakovina therapeutics incResearch assistance programDrug administrationAmerican association of cancer researchCanada researchRakovina therapeutics inc david hymanchief financial officerHealth canada

Rakovina Therapeutics Inc Announces 2022 Financial Results

VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company.

Comunidad autonoma de catalunaUnited kingdomBritish columbiaUnited statesDavid hymanJeffrey bachaDrug administrationHealth canadaProactive investors nort america incRegulation services providerNational brain tumor societyAmerican association of cancer researchResearch developmentNational research council of canadaVenture exchangeRakovina therapeutics inc

Lyon, France – 12 April 2023 – 6pm CEST – Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases and pioneer in the development of drug. | April 12, 2023

France generalUnited statesWorldsymposium orlandoMarco sardielloInserm transfertMathieu charvEmyr lloyd evansClaude bernard lyonResearch associationCardiff university united kingdomBaylor college of medicine houstonTranslational research conference for the managementAtomic energy commissionResearch tax creditFrench national institute of healthFederation of european neurosciences societies

THERANEXUS AND BBDF PRESENT PROGRESS ON THE BATTEN-1 PROGRAM AT THE TRANSLATIONAL RESEARCH CONFERENCE FOR THE MANAGEMENT OF NCLS ON 3 AND 4 NOVEMBER, 2022 IN CHICAGO

Lyon, France - Austin, Texas, United States - 2 November 2022 - 6pm CET - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development

United statesFrance generalThierry lambertMathieu charvFlorence portejoieMartin pierre laurentEmyr lloyd evansCardiff university school of biosciencesNational organization for rare disordersTranslational research conference for the managementAtomic energy commissionBatten disease foundationBeyond batten disease foundationCardiff universityTranslational research conferenceCardiff university school